ISU Abxis Co. Ltd (086890) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.088x

Based on the latest financial reports, ISU Abxis Co. Ltd (086890) has a cash flow conversion efficiency ratio of 0.088x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.56 Billion ≈ $7.15 Million USD) by net assets (₩120.39 Billion ≈ $81.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ISU Abxis Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how ISU Abxis Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of ISU Abxis Co. Ltd for a breakdown of total debt and financial obligations.

ISU Abxis Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ISU Abxis Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
MFEC PCL BK:MFEC	-0.040x
Nova Minerals Limited NYSE MKT:NVA	0.066x
Kothari Petrochemicals Limited NSE:KOTHARIPET	0.144x
Immutep Ltd ADR NASDAQ:IMMP	-0.284x
U-Best Polymer Industry Co Ltd TWO:4714	0.000x
GAMING INNOVATION DL 1 F:GI11	N/A
Compagnie Industrielle et Financière d'Entreprises SA PA:INFE	0.143x
SRP Groupe SA PA:SRP	0.135x

Annual Cash Flow Conversion Efficiency for ISU Abxis Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of ISU Abxis Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see ISU Abxis Co. Ltd (086890) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩100.86 Billion ≈ $68.35 Million	₩2.54 Billion ≈ $1.72 Million	0.025x	+172.20%
2023-12-31	₩77.19 Billion ≈ $52.31 Million	₩-2.69 Billion ≈ $-1.82 Million	-0.035x	-459.13%
2022-12-31	₩64.41 Billion ≈ $43.65 Million	₩-401.66 Million ≈ $-272.20K	-0.006x	+92.31%
2021-12-31	₩71.95 Billion ≈ $48.76 Million	₩-5.84 Billion ≈ $-3.96 Million	-0.081x	+58.72%
2020-12-31	₩43.57 Billion ≈ $29.53 Million	₩-8.56 Billion ≈ $-5.80 Million	-0.197x	+17.50%
2019-12-31	₩55.18 Billion ≈ $37.40 Million	₩-13.15 Billion ≈ $-8.91 Million	-0.238x	-6.37%
2018-12-31	₩59.73 Billion ≈ $40.48 Million	₩-13.38 Billion ≈ $-9.07 Million	-0.224x	-101.74%
2017-12-31	₩62.05 Billion ≈ $42.05 Million	₩-6.89 Billion ≈ $-4.67 Million	-0.111x	-86.96%
2016-12-31	₩45.58 Billion ≈ $30.89 Million	₩-2.71 Billion ≈ $-1.83 Million	-0.059x	+28.68%
2015-12-31	₩46.59 Billion ≈ $31.57 Million	₩-3.88 Billion ≈ $-2.63 Million	-0.083x	+87.39%
2014-12-31	₩17.41 Billion ≈ $11.80 Million	₩-11.49 Billion ≈ $-7.79 Million	-0.660x	--

About ISU Abxis Co. Ltd

KQ:086890 Korea Pharmaceuticals

Market Cap

$83.90 Million

₩123.81 Billion KRW

Market Cap Rank

#19858 Global

#1134 in Korea

Share Price

₩4650.00

Change (1 day)

-2.31%

52-Week Range

₩4410.00 - ₩6240.00

All Time High

₩22450.00